Target intelligence / Profile preview

TMEM230 pseudogene 1 (TMEM230P1)

Target
TMEM230P1
01

Overview

TMEM230 pseudogene 1 (TMEM230P1) is a pseudogene, meaning it is a non-functional genomic sequence similar to the TMEM230 gene but does not encode a functional transmembrane protein. Pseudogenes lack the molecular properties and disease associations of their parent genes. The functional TMEM230 protein is a multi-pass transmembrane protein, highly expressed in the neuronal vesicles and vascular compartments, and implicated in the trafficking and recycling of synaptic vesicles, neurodegeneration (e.g., Parkinson's disease, dementia), and tumor angiogenesis[1][2][3][4]. There is no evidence in the literature linking TMEM230P1 itself to disease, drug interactions, biomarkers, or any therapeutic applications. If your interest is in the druggable target, disease roles, or biology of TMEM230, consult entries for TMEM230 (Transmembrane Protein 230), not TMEM230P1 or any other pseudogene variants[4]. The parent gene and protein are relevant for synaptic vesicle trafficking, neurodegeneration, angiogenesis, and may constitute a therapeutic target[1][2][3][4]. Pseudogenes, such as TMEM230P1, do not typically produce a functional product and do not qualify as receptors or therapeutic targets.

Beyond the preview

Go deeper on TMEM230 pseudogene 1 (TMEM230P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMEM230 pseudogene 1 (TMEM230P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call